Risk of mortality during cancer treatment in relation to BMI (IMAGE)

Osaka Metropolitan University

Risk of mortality during cancer treatment in relation to BMI

Caption

For non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal for persons who might be overweight or obese.

Credit

Osaka Metropolitan University

Usage Restrictions

News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.